metronidazole has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezerra da Silva, LA; Cardoso, CR; da Silva, JS; Faria, G; Kuga, MC; Pereira, MS; Rossi, MA | 1 |
| Aung, PP; Curry, JL; Farah, M; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA | 1 |
2 other study(ies) available for metronidazole and transforming growth factor beta
| Article | Year |
|---|---|
Cellular and molecular tissue response to triple antibiotic intracanal dressing.
Topics: Animals; Anti-Bacterial Agents; Calcium Hydroxide; Ciprofloxacin; Collagen; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Interleukin-17; Interleukin-1beta; Male; Metronidazole; Mice; Mice, Inbred BALB C; Microvessels; Minocycline; Neutrophils; Root Canal Irrigants; Subcutaneous Tissue; Time Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2014 |
Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chondrosarcoma; Clobetasol; Drug Therapy, Combination; Humans; Hyperpigmentation; Lichen Planus; Male; Metronidazole; Transforming Growth Factor beta; Treatment Outcome | 2020 |